Cadrenal Therapeutics
CVKD
CVKD
16 hedge funds and large institutions have $1.22M invested in Cadrenal Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+6
Holders Change %
+60%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$805K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$111K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$27K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$17.6K |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$3.18K |
Top Sellers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.33K |
| 2 |
RS
R Squared
Central,
Hong Kong
|
-$580 |
| 3 |
Morgan Stanley
New York
|
-$282 |
